Efficient scavenging of fatty acid oxidation products by aminoguanidine

Chemical Research in Toxicology

Volumn 10, Issue 8, 1997, Pages 875-879

  Al Abed, Yousef ^a   Bucala, Richard ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; AMINOGUANIDINE; FATTY ACID; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; FATTY ACID OXIDATION; GLYCATION; LIPID OXIDATION; LIPOPROTEIN METABOLISM; OXIDATIVE STRESS;

ALDEHYDES; FATTY ACIDS; GUANIDINES; MALONDIALDEHYDE; OXIDATION-REDUCTION;

EID: 0030854637     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx970035l     Document Type: Article

References (23)

1. Halliwell, B. (1987) Oxidants and human disease: some new concepts. FASEB J. 1, 358-364.
2. Witztum, J. L., and Steinberg, D. (1991) Role of oxidized low density lipoprotein in atherogenesis. J. Clin. Invest. 88, 1785-1792.
3. Frankel, E. N. (1980) Lipid oxidation. Prog. Lipid Res. 19, 1-22.
4. Gardner, H. W. (1989) Oxygen radical chemistry of polyunsaturated fatty acids. Free Radical Biol. Med. 7, 65-86.
5. Esterbauer, H., Schaur, R. J., and Zollner, H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radical Biol. Med. 11, 81-128.
6. 2 biosynthesis. J. Biol. Chem. 264, 141-150.
7. Schauenstein, E., Dorner, F., and Sonnenbichler, J. (1968) Reaction of glutathione with conjugated carbonyls. Z. Naturforsch. 23b, 316-319.
8. Esterbauer, H., Ertl, A., and Scholz, N. (1976) The reaction of cysteine with alpha-beta-unsaturated aldehydes. Tetrahedron 32, 285-289.
9. Sayre, L. M., Arora, P. K., Iyer, R. S., and Salomon, R. G. (1993) Pyrrole formation from 4-hydroxynonenal and primary amines. Chem. Res. Toxicol. 6, 19-22.
10. Nadkarni, D. V., and Sayre, L. M. (1995) Structural definition of early lysine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284-291.
11. Bucala, R., Makita, Z., Koschinsky, T., Cerami, A., and Vlassara, H. (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc. Natl. Acad. Sci. U.S.A. 90, 6434-6438.
12. Bucala, R., and Cerami, A. (1992) Advanced glycosylation: Chemistry, biology, and implications for diabetes and aging. Adv. Pharmacol. 23, 1-34.
13. Ledl, F., and Schleicher, E. (1990) New aspects of the Maillard reaction in foods and in human body. Angew. Chem., Int. Ed. Engl. 29, 565-594.
14. Bucala R., Makita, Z., Vega, G., Grundy, S., Koschinsky, T., Cerami, A., and Vlassara, H. (1994) Modification of LDL by advanced glycosylation end products contributes to the dyslipidemia of diabetes and renal insufficiency. Proc. Natl. Acad. Sci. U.S.A. 91, 9441-9445.
15. Bucala, R., Mitchell, R., Arnold, K., Innerarity, T., Vlassara, H., and Cerami, A. (1995) Identification of the major site of apolipoprotein-B modification by advanced glycosylation end products (AGEs) blocking uptake by the LDL receptor. J. Biol. Chem. 270, 10828-10832.
16. Al-Abed Y., Liebich, H., Voelter, W., and Bucala, R. (1996) Hydroxalkenal formation induced by LDL-advanced glycosylation. J. Biol. Chem. 271, 2892-2896.
17. Vlassara, H., Fuh, H., Makita, Z., Krungkrai, S., Cerami, A., and Bucala, R. (1992) Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc. Natl. Acad. Sci. U.S.A. 89, 12043-12047.
18. Jerums, G., Soulis-Liparota, T., Panagiotopoulos, S., and Cooper, M. E. (1994) In Maillard Reactions in Chemistry, Food, and Health (Labuza, T. P., Reineccius, G. A., Monnier, V. M., O'Brien, J., and Baynes, J. W., Eds.) Royal Society of Chemistry, Cambridge, U.K.
19. Chen, H.-J., and Cerami, A. (1993) J. Carbohydr. Chem. 12, 731-742.
20. Makita, Z., Vlassara, H., Rayfield, E., Cartwright, K., Friedman, E., Rodby, R., Cerami, A., and Bucala, R. (1992) Hemoglobin-AGE: a circulating marker of advanced glycosylation. Science 258, 651-653.
21. Requena, J. R., Vidal, P., and Cabezas-Cerrato, J. (1992) Aminoguanidine inhibits the modification of proteins by lipid peroxidation derived aldehydes: a possible antiatherogenic agent. Diabetes Res. 20, 43-49.
22. Picard, S., Parthasarathy, S., Fruebis, J., and Witztum, J. L. (1992) Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors. Proc. Natl. Acad. Sci. U.S.A. 89, 6876-6880.
23. Esterbauer, H., and Weger, W. (1967) The effect of aldehydes on normal and malignant cells. 2nd report: Synthesis of homologous 4-hydroxy-2-alkenals. Monatsh. Chem. 98, 1994-2000.